DCAT Value Chain Insights

Business Continuity Planning After COVID-19

An upcoming DCAT benchmarking study is examining the lessons learned and risk-mitigation practices taken by bio/pharma companies and suppliers in the wake of the COVID-19 pandemic. What best...

Company on the Move: Viatris

Viatris is the new company formed from the combination of Upjohn, Pfizer’s off-patent branded and generic established medicines business, and Mylan. The companies had announced the deal in July...

SPONSORED CONTENT

Advancing Gene Therapy by Solving Challenges in Scale-Up & Manufacturing

Information
November 11, 2020
Sponsored by Avantor

Today’s biologic drugs give the promise of breakthrough treatment options for the world’s most challenging diseases and chronic conditions. In the case of gene therapies, the impact of these...

Read More
New Choices to Help Improve mAbs Downstream Manufacturing Efficiency: Introducing the J.T.Baker® BAKERBOND® PROchievA™ Recombinant Protein A Resin

Information
October 7, 2020
Sponsored by Avantor

An integrated mAbs downstream purification process featuring Avantor J.T.Baker® BAKERBOND® PROchievA™ recombinant protein A chromatography columns and resins can enable significant throughput...

Read More
Small-Molecule Matters: Integration in Drug Development

Information
September 8, 2020
Sponsored by Cambrex

How a collaborative approach between small and large drug developers with the right CDMO can overcome critical challenges to achieve greater efficiencies in quality, time, and cost – at every stage...

Read More